ALS biomarkers for therapy development: State of the field and future directions.
about
Report on the 3rd Ottawa International Conference on Neuromuscular Biology, Disease and Therapy - September 24-26, 2015, Ottawa, Canada.Urinary p75ECD: A prognostic, disease progression, and pharmacodynamic biomarker in ALS.Urinary Extracellular Domain of Neurotrophin Receptor p75 as a Biomarker for Amyotrophic Lateral Sclerosis in a Chinese cohortDrugs in clinical development for the treatment of amyotrophic lateral sclerosis.Assessment of Motor Units in Neuromuscular Disease.Management and therapeutic perspectives in amyotrophic lateral sclerosis.MicroRNA Metabolism and Dysregulation in Amyotrophic Lateral Sclerosis.Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.Genetic analysis of patients with familial and sporadic amyotrophic lateral sclerosis in a Brazilian Research Center.Magnetic resonance imaging based anatomical assessment of tongue impairment due to amyotrophic lateral sclerosis: A preliminary study.Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis
P2860
Q30355125-04C4FC5E-03A9-4C99-9EA3-D294D31D9BDEQ37730505-35EB177C-F197-4926-8312-2829DA02F886Q38683234-39B9C82A-0960-429E-9DE5-92A9FF73F76CQ38748144-DAD41214-F38E-470F-86FD-4C13C901CAF5Q38947718-E941F1B9-4530-404F-A4A9-4116B77285BFQ38958585-326DB10E-5FE2-4934-A273-0BDA2C173890Q39250013-8BA775BD-8F45-427F-B402-369DB5B5ADC5Q42369773-CD56ECA1-3E3C-4DFB-ACAC-CD385D10216FQ47606766-485083FE-83A0-48AF-80A0-C052AC6CF17AQ55012378-10FE9723-2D97-4948-843C-11F288558B8BQ56525449-C3F50F48-C854-4E9C-ACAC-14860B6FCBA0
P2860
ALS biomarkers for therapy development: State of the field and future directions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
ALS biomarkers for therapy development: State of the field and future directions.
@ast
ALS biomarkers for therapy development: State of the field and future directions.
@en
type
label
ALS biomarkers for therapy development: State of the field and future directions.
@ast
ALS biomarkers for therapy development: State of the field and future directions.
@en
prefLabel
ALS biomarkers for therapy development: State of the field and future directions.
@ast
ALS biomarkers for therapy development: State of the field and future directions.
@en
P2093
P2860
P356
P1433
P1476
ALS biomarkers for therapy development: State of the field and future directions.
@en
P2093
Andreas Jeromin
James Berry
Kevin Boylan
Lucie Bruijn
Nazem Atassi
Seward B Rutkove
P2860
P304
P356
10.1002/MUS.24979
P577
2015-11-17T00:00:00Z